Migraine Linked to Higher Risk of Pregnancy Complications in Preliminary Study
Researchers also found that women with migraine with aura had a higher risk of preeclampsia than those with migraine without aura.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 28, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Mepolizumab Clinically Effective Regardless of Type 2 Biomarker Status in Patients with Severe Asthma, Suggests Real-world Data
AAAAI 2022: Mepolizumab found effective in standard clinical care regardless of type 2 eosinophil biomarker status in patients with severe asthma.
Novel Agent for Severe Asthma Halves Exacerbation Rates Across Respiratory Comorbidities
Tezepelumab, a TSLP inhibitor, reduced asthma exacerbation rates in patients with severe uncontrolled disease across a range of respiratory comorbidities.
American Academy of Asthma, Allergy & Immunology 2022 News Highlights
AAAAI late-breaking science and findings that could change your treatment plan for patients with severe asthma, summarized by our editors for easy access.
Dupilumab Found to Improve Clinical, Histologic Aspects of Eosinophilic Esophagitis
AAAAI 2022: New study found patients with eosinophilic esophagitis who received dupilumab experienced clinically meaningful improvements in symptoms.
Dupilumab Significantly Decreased Itch and Hives in Patients with Chronic Spontaneous Urticaria
Dupilumab significantly reduced itch and hives in patients with H1 antihistamine-resistant chronic spontaneous urticaria, according to new research.
Asthma May be Linked to Severe COVID-19 but Not to Risk for Hospitalization
Patients with asthma who did require hospitalization for SARS-CoV-2 infection were at greater risk for intubation and remdesivir treatment, a new study reports.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 25, 2022
Fostering Wellbeing in School-aged Children during COVID-19
How can clinicians help parents of school-aged children foster wellbeing now that pediatric COVID-19 vaccination and booster doses are recommended?
FDA Grants Empagliflozin Broad Heart Failure Indication
The landmark approval for the SGLT-2 inhibitor will open access to treatment for the ~ 3 million adults with heart failure with preserved ejection fraction.
Sexual Assault, Workplace Harassment Raises Hypertension Risk in Middle-aged Women
A study of midlife women found those with a history of both sexual assault and workplace sexual harassment had the highest risk of hypertension.
Regular Use of Acetaminophen May Significantly Increase Hypertension and CV Risk
In the PATH-BP study, use of acetaminophen 4g/day increased BP among patients with hypertension by nearly 5 mm Hg within 2 weeks of beginning the regimen.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 24, 2022
COVID-19 vs Influenza: 7 Questions on What Makes Them Different
From transmission to treatment, COVID-19 and flu have several similarities and differences. Knowing how they differ will be the key to diagnosis this flu season.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 23, 2022
FDA Grants Clearance to First Smartphone App for Programming Insulin Dosing
t:slim X2 insulin pump users can now program or cancel bolus dosing with the secure t:connect mobile app already on their phones, says Tandem Diabetes Care.
Severe Asthma Research Quiz: 8 Questions on Notable New Findings
New study findings on asthma exacerbation risk prediction, rapid steroid reduction, and patient perception of disease lead this quick quiz.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 22, 2022
Racial/Ethnic Bias Found in Asthma Clinical Trials Used to Update NHLBI Guideline
In the majority of studies that reported racial/ethnic data, White participants were highly overrepresented and Black/Hispanic/all Other underrepresented.